Fundraising Fox
TYBR Health
YC W22Houston, US · Founded 2020 · Delaware corporation · 3 employees · 8 known investors
Find your way into TYBR Health
Sign up to see every warm intro you have to TYBR Health
- Paths you didn't know you had: your email and LinkedIn already hold routes to the TYBR Health team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Tybrhealth develops the B3 GEL™ System, a protective gel applied during tendon and ligament repair surgery to reduce post-operative scar formation and preserve tissue mobility. The product is marketed to surgeons seeking to improve functional outcomes for patients recovering from tendon repair procedures.
Founders & leadership· Y Combinator alumni (W22)
TYBR Health was founded in 2020 by Tim Keane, Alex Smith, Jeffrey Tyber, and P. Alex Smith.
Board
Investors · 8
How we know: Arieal Southeast Angel Partners's portfolio page · Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · eightcapital.com · Not right? Tell us
How we know: press coverage · venturesouq.com · Y Combinator's founder network · Not right? Tell us
How we know: the Y Combinator directory · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: board seat on SEC Form D · offering press articles · Not right? Tell us
How we know: board seat on SEC Form D · offering press articles · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$22.2M disclosed across 3 rounds · 2020–2026
▶$14.4MraisedJul 2026 · 12 investors · BiotechnologyRule 506(b)
- Timothy J. Keane Jr.Executive Officer, Director
- Alex SmithExecutive Officer, Director
- Aaron SmithDirector
- Jeffrey TyberDirector
- Greg BankerDirector
- Liz ZamboryDirector
- Toby HamiltonDirector
- Offering amount
- $30M
- Amount sold
- $14.4M
- First sale
- Jul 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.1MraisedNov 2025 · 50 investors · BiotechnologyRule 506(b)
- Toby HamiltonDirector
- Timothy J. KeaneExecutive Officer, Director
- Alex SmithDirector
- Tom DuganDirector
- Jeffrey TyberDirector
- Offering amount
- $7.9M
- Amount sold
- $7.1M
- First sale
- Jan 2025
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$710KraisedDec 2020 · 8 investors · Other Health CareRule 506(b)
- Timothy J. Keane, Jr.Executive Officer, Director, Promoter
- Alex SmithExecutive Officer, Director, Promoter
- Stephen RamonExecutive Officer
- Cooper CollinsDirector
- Offering amount
- $1.3M
- Amount sold
- $710K
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 6
Companies working in the same space as TYBR Health.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $269.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $256.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $256K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Legal entities · 1
corporate structureFrequently asked questions
- What does TYBR Health do?
- Tybrhealth develops the B3 GEL™ System, a protective gel applied during tendon and ligament repair surgery to reduce post-operative scar formation and preserve tissue mobility. The product is marketed to surgeons seeking to improve functional outcomes for patients recovering from tendon repair procedures.
- Who founded TYBR Health?
- TYBR Health was founded by Tim Keane, Alex Smith, Jeffrey Tyber, P. Alex Smith in 2020.
- Who are TYBR Health's investors?
- TYBR Health's investors include Arieal Southeast Angel Partners, Asymmetry Ventures, Eight Capital, VentureSouq, Y Combinator, MEDA Angels, Mutual Capital Partners, Vensana Capital.
- How much funding has TYBR Health raised?
- TYBR Health has disclosed $22.2M raised across 3 rounds.
- Where is TYBR Health headquartered?
- TYBR Health is headquartered in Houston, US.